Florida HB 1281: Interception and Disclosure of Oral Communications
Status: Chapter No. 2024-131 (as of 2024-04-29)
State: Florida · Session: 2024 · Bill: HB 1281
Subjects: subject index
Sponsors: Criminal Justice Subcommittee, Joseph, Persons-Mulicka, López, J.
Bill Text
HB 1281 2026 CODING: Words stricken are deletions; words underlined are additions. hb1281-00 Page 1 of 22 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S A bill to be entitled 1 An act relating to prohibitions against discriminatory 2 practices relating to 340B entities and 340B drugs; 3 providing a short title; creating s. 499.061, F.S.; 4 providing definitions; prohibiting drug manufacturers 5 from engaging in certain acts against the acquisitions 6 of 340B drugs by and the delivery of such drugs to 7 specified pharmacies; providing an exception; 8 prohibiting drug manufacturers from interfering with 9 pharmacies' rights to contract with 340B entities; 10 providing that each commission of certain acts 11 constitutes a violation of the Florida Deceptive and 12 Unfair Trade Practices Act and subjects the violator 13 to certain actions and penalties; providing 14 construction and applicability; creating s. 626.8829, 15 F.S.; providing definitions; prohibiting health 16 insurance issuers, pharmacy benefit managers, and 17 other third-party payors, and agents thereof, from 18 engaging in certain discriminatory acts relating to 19 reimbursement to 340B entities for 340B drugs; 20 providing applicability; providing that each 21 commission of certain acts constitutes a violation of 22 the Florida Deceptive and Unfair Trade Practices Act 23 and subjects the violator to certain actions and 24 penalties; providing construction; creating ss. 25 HB 1281 2026 CODING: Words stricken are deletions; words underlined are additions. hb1281-00 Page 2 of 22 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S 627.64743, 627.65733, and 641.31543, F.S.; providing 26 definitions; prohibiting individual health insurers, 27 group, blanket, and franchise health insurers, and 28 health maintenance organizations, respectively, and 29 pharmacy benefit managers on behalf of these insurers 30 and health maintenance organizations, from engaging in 31 certain discriminatory acts relating to reimbursement 32 to 340B entities for 340B drugs; providing 33 applicability; providing that each commission of 34 certain acts constitutes a violation of the Florida 35 Deceptive and Unfair Trade Practices Act and subjects 36 the violator to certain actions and penalties; 37 providing construction; providing an effective date. 38 39 Be It Enacted by the Legislature of the State of Florida: 40 41 Section 1. This act may be cited as the "Defending 42 Affordable Prescription Drug Costs Act." 43 Section 2. Section 499.061, Florida Statutes, is created 44 to read: 45 499.061 Prohibitions against manufacturers' discriminatory 46 practices relating to 340B drugs and 340B entities.— 47 (1) As used in this section, the terms: 48 (a) "340B drug" means a drug that has been subject to any 49 offer for reduced prices by a manufacturer pursuant to 42 U.S.C. 50 HB 1281 2026 CODING: Words stricken are deletions; words underlined are additions. hb1281-00 Page 3 of 22 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S s. 256b and is purchased by a covered entity as defined in 42 51 U.S.C. s. 256b(a)(4). 52 (b) "340B entity" means an entity participating or 53 authorized to participate in the 340B Drug Pricing Program, as 54 described in 42 U.S.C. s. 256b, including its pharmacy, or any 55 pharmacy contracted with the participating entity to dispense 56 drugs purchased through the 340B Drug Pricing Program. 57 (2) A manufacturer may not: 58 (a) Deny, restrict, prohibit, or otherwise interfere with, 59 directly or indirectly, the acquisition of a 340B drug by, or 60 delivery of a 340B drug to, a pharmacy that is under contract 61 with a 340B entity and is authorized under such contract to 62 receive and dispense 340B drugs on behalf of the covered entity 63 unless such receipt is prohibited by the United States 64 Department of Health and Human Services; or 65 (b) Interfere with a pharmacy's right to contract with a 66 340B entity. 67 (3) The commission of any act prohibited by this section 68 is a deceptive and unfair trade practice and constitutes a 69 violation of the Florida Deceptive and Unfair Trade Practices 70 Act under part II of chapter 501, and subjects the violator to 71 all actions, including, but not limited to, investigative 72 demands, remedies, and penalties provided for in the Florida 73 Deceptive and Unfair Trade Practices Act. Each commission of a 74 prohibited act constitutes a violation of the Florida Deceptive 75 HB 1281 2026 CODING: Words stricken are deletions; words underlined are additions. hb1281-00 Page 4 of 22 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S and Unfair Trade Practices Act. 76 (4) This section may not be construed to be less 77 restrictive than federal law for a person or entity to which 78 this section applies. This section may not be construed to be in 79 conflict with any of the following: 80 (a) Applicable federal law or regulations. 81 (b) Other laws of this state which are compa
View Florida HB 1281 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.